Abstract
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer — A Multicentre Single-Arm Phase II Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have